Recently, we showed that global deficiency of the nuclear receptor RORα in the “staggerer” mouse exacerbates angiotensin II–induced cardiac hypertrophy and compromises cardiomyocyte mitochondrial function. The gene discussed is RORA; the disease is hypertrophy.